Synergistic TTFields Delivery Systems

Publication ID: 24-11857782_0003_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic TTFields Delivery Systems,” Published Technical Disclosure No. 24-11857782_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857782_0003_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,782.

Summary of the Inventive Concept

Integrating implantable transducer arrays with distinct technologies like AI, IoT, blockchain, and novel materials to create more effective and personalized tumor treating fields (TTFields) delivery systems.

Background and Problem Solved

The original Optune system has limitations in delivering TTFields to patients, including skin irritation, discomfort, and limited treatment efficacy. The new inventive concept addresses these limitations by integrating implantable transducer arrays with advanced technologies to enhance treatment outcomes and patient experience.

Detailed Description of the Inventive Concept

The synergistic TTFields delivery systems combine implantable transducer arrays with AI modules for real-time optimization, IoT networks for remote monitoring, blockchain-based data storage for secure patient records, wearable devices for patient input, and novel material compositions for enhanced sensing capabilities. These integrations enable personalized TTFields treatment protocols, improved treatment efficacy, and enhanced patient experience.

Novelty and Inventive Step

The new claims introduce novel combinations of implantable transducer arrays with AI, IoT, blockchain, and novel materials, providing a non-obvious and innovative approach to TTFields delivery. The inventive step lies in the synergistic integration of these distinct technologies to create a more powerful and effective system.

Alternative Embodiments and Variations

Alternative embodiments may include integrating the implantable transducer arrays with other technologies like robotics, augmented reality, or 5G networks. Variations may include using different AI algorithms, IoT protocols, or blockchain architectures to achieve similar synergistic effects.

Potential Commercial Applications and Market

The synergistic TTFields delivery systems have significant commercial potential in the oncology market, particularly in treating glioblastoma and other aggressive tumors. The integration of advanced technologies can provide a competitive edge in the market, offering improved treatment outcomes and enhanced patient experience.

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Biomedical engineering, specifically medical device technologies for tumor treatment, with expertise in electromagnetic field therapy, implantable medical devices, and signal delivery systems

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device specialist with advanced degree, understanding of electromagnetic field therapies, implantable medical technologies, signal processing, and interdisciplinary medical technology integration

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies with implantable medical devices represents a predictable evolution of medical treatment systems. The source patent's core innovation of implantable transducer arrays provides a natural foundation for incorporating advanced monitoring and personalization technologies. The proposed variations represent logical extensions of existing medical device integration strategies, utilizing well-established technological approaches to enhance treatment precision and patient outcomes.

Obvious Combinations & Variations

Source Patent Element

Implantable transducer arrays for delivering tumor treating fields

PTD Variation

Integration of AI modules for real-time treatment optimization

Obviousness Reasoning

Applying machine learning to medical device performance is a known technique for improving treatment precision, representing a predictable application of computational technologies to existing medical devices

Source Patent Element

Multiple electrode element configurations for TTFields delivery

PTD Variation

IoT network integration for remote monitoring and control

Obviousness Reasoning

Implementing remote monitoring in medical devices is a standard approach in contemporary medical technology, providing a predictable enhancement to existing implantable device functionality

Source Patent Element

Temperature sensing capabilities in implantable arrays

PTD Variation

Novel material compositions with nanomaterial-based sensing elements

Obviousness Reasoning

Enhancing sensing capabilities through advanced materials represents a routine design optimization approach in medical device engineering, utilizing known strategies for improving device performance

Source Patent Element

Electrode arrays configured for implantation within a person's body

PTD Variation

Blockchain-based secure data storage for patient records

Obviousness Reasoning

Implementing secure data management technologies in medical devices is a foreseeable technological progression, addressing known challenges in patient data protection

Source Patent Element

Capacitively coupled electrode elements

PTD Variation

Genomic profiling module for personalized treatment protocols

Obviousness Reasoning

Integrating patient-specific data analysis with medical device functionality represents a logical extension of precision medicine approaches, utilizing known computational techniques

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857782 and the disclosed technological variations, a person of ordinary skill in the art would find the proposed TTFields delivery system modifications obvious and predictable. The integration of AI, IoT, blockchain, and advanced materials with implantable transducer arrays represents a straightforward technological progression that would be apparent to a skilled practitioner, thereby rendering potential patent claims covering such variations unpatentable under 35 U.S.C. Section 103.

Original Patent Information

Patent Number	US 11,857,782
Title	Delivering tumor treating fields (TTFields) using implantable transducer arrays
Assignee(s)	Novocure GmbH